ArticleBiological trace element research2026
Neuroprotective Effects of Alpha-Lipoic Acid Against Behavioral Toxicity, Oxidative and Inflammatory Damage Caused by Titanium Dioxide Nanoparticles.
Article in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Titanium dioxide nanoparticles (TiO₂-NPs) are used widely in various industries, but emerging evidence suggests their ability to elicit neurotoxicity. The present study evaluated the alpha-lipoic acid (ALA) neuroprotective potential against TiO₂-NP-induced cognitive and molecular impairments in male Sprague-Dawley rats. Twenty-four rats were allocated into four groups: negative control, TiO₂-NPs (150 mg/kg, i.p.), ALA (50 mg/kg, orally), and TiO₂-NPs + ALA. Treatments were administered on alternate days for 28 days. Neurobehavioral tests, including the open field test (OFT), elevated plus maze (EPM), novel object recognition test (NORT), and Morris water maze (MWM), revealed that TiO₂-NPs impaired memory and increased anxiety-like behavior, while ALA co-treatment significantly restored behavioral performance. TiO₂-NPs exposure significantly decreased antioxidant enzymes (SOD, CAT, GSH), increased lipid peroxidation (MDA), elevated proinflammatory cytokines (TNF-α, IL-6), and apoptotic marker (caspase-3), and reduced neurotransmitter levels (GABA and dopamine). ALA administration reversed these alterations, indicating antioxidant, anti-inflammatory, and neuroprotective effects. Gene expression analysis showed TiO₂-NPs upregulated BAX, NF-κB, APP, and MAPT and downregulated BCL-2 and Nrf2, consistent with neurodegenerative and apoptotic signaling. ALA co-treatment normalized these gene expressions. Histopathological analysis confirmed structural damage in the cerebrum and cerebellum after TiO₂-NPs exposure, which ALA markedly improved. These findings suggest that ALA offers significant neuroprotection against TiO₂-NP-induced toxicity via its antioxidant, anti-inflammation, and anti-apoptosis properties, and supports being a potential protective agent against nanoparticle-induced neurodegeneration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.